Crescent Biopharma, Inc. (CBIO) ownership: Top institutional holder: FMR LLC ($75.93M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 4133514.00 | $75.93M | 2026-03-31 |
| BVF INC/IL | 2748763.00 | $50.49M | 2026-03-31 |
| Fairmount Funds Management LLC | 2747866.00 | $50.48M | 2026-03-31 |
| Venrock Adviser, LLC | 2133576.00 | $39.19M | 2026-03-31 |
| FCPM III SERVICES B.V. | 1677852.00 | $30.82M | 2026-03-31 |
| Balyasny Asset Management L.P. | 1510033.00 | $27.74M | 2026-03-31 |
| Vestal Point Capital, LP | 1500000.00 | $27.55M | 2026-03-31 |
| Opaleye Management Inc. | 1312615.00 | $24.11M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 |
Back to CBIO overview · CBIO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.